Research Center

GTJASVN_MWG Equity Report_Back to the growth trajectory_TP80496VND Hold_Oct 14 2025

15/10/2025

Share:

GTJASVN_MWG Equity Report_Back to the growth trajectory_TP80496VND Hold_Oct 14 2025

MWG is returning to a new growth cycle in 2025–2030 with three key drivers:
(1) Recovery of the ICT and electronics segments after restructuring, reducing the number of stores (-7%) while increasing revenue quality (+20%) compared to the beginning of the year. Revenue is expected to reach VND 100,600 billion (+12% YoY). MWG is preparing an IPO plan for the Era Blue chain in Indonesia after 2027. The chain’s business performance has improved significantly; after the pilot phase in 2023–2024, Era Blue has opened 124 stores, all of which are profitable.

(2) BHX is becoming the primary growth engine with an IPO planned in 2028, which will help re-rate MWG’s valuation. It has strong growth momentum driven by successful expansion in the Central region along with plans to expand to the North, and is expected to deliver around VND 500 billion in net profit this year (+40% YoY). However, MWG’s ambition to list BHX early can be realized still depends on BHX’s accumulated losses of more than VND 6,900 billion can return to positive retained earnings.

(3) Business efficiency improves thanks to the expansion of the online segment: leveraging the strong e-commerce infrastructure of TGDĐ/ĐMX, BHX also targets to increase the online revenue contribution from 5% to 10% within the next two years. The online channel helps reduce rental pressure, thereby supporting profit margins.

In addition, the AvaKid segment and An Khang Pharmacy have not shown significant breakthroughs yet; we will continue to update developments in upcoming reports.

VALUATION AND RECOMMENDATION

We apply the SOTP valuation method and determine the fair value for MWG at VND 80,496 per share, with a “Hold” recommendation. MWG is entering a favorable business cycle with BHX as its main growth driver. In the long term, the IPO plans of its subsidiary retail chains are key catalysts that may help re-rate the company’s valuation.

 

Danh sách báo cáo liên quan

GTJASVN RS_FRT Equity Report _Long Chau pharmacy chain continues to spearhead growth _TP188,687_Feb 4, 2026

05/02/2026

(EN) GTJASVN RS_FRT Equity Report _Long Chau pharmacy chain continues to spearhead growth _TP188,687_Feb 4, 2026 BUSINESS UPDATES According to the FY2025...

(EN) GTJASVN_MBB Equity Report_2025 Business Results_Accumulate TP29,600VND_03.02.2026

03/02/2026

(EN) GTJASVN_MBB Equity Report_2025 Business Results_Accumulate TP29,600VND_03.02.2026 KEY BUSINESS HIGHLIGHTS In 2025, MBB recorded exceptional growth...

(EN) GTJASVN Research_Vietnam Stock Market Outlook 2026_CATCHING THE BIG CURRENT_Jan 2026

29/01/2026

2026 INVESTMENT STRATEGY Entering 2026, the global and Vietnamese investment landscape continues to present a core paradox: “the most efficient is not...

Contact

    For compliance information, please contact:

    compliance@gtjas.com.vn

    • Stock index
    • VNINDEX: 1761.24   -21.32   (-1.2%)
    • HNX: 258.86   -4.18   (-1.59%)